ProShare Advisors’s Keros Therapeutics KROS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-10,549
| Closed | -$167K | – | 2172 |
|
|
2024
Q4 | $167K | Buy |
10,549
+2,764
| +36% | +$43.8K | ﹤0.01% | 1938 |
|
|
2024
Q3 | $452K | Buy |
7,785
+2,118
| +37% | +$123K | ﹤0.01% | 1193 |
|
|
2024
Q2 | $259K | Sell |
5,667
-1,469
| -21% | -$67.1K | ﹤0.01% | 1391 |
|
|
2024
Q1 | $472K | Buy |
7,136
+1,496
| +27% | +$99K | ﹤0.01% | 1124 |
|
|
2023
Q4 | $224K | Buy |
+5,640
| New | +$224K | ﹤0.01% | 1576 |
|
|
2023
Q1 | – | Sell |
-4,753
| Closed | -$228K | – | 1857 |
|
|
2022
Q4 | $228K | Buy |
+4,753
| New | +$228K | ﹤0.01% | 1403 |
|
|
2022
Q2 | – | Sell |
-5,349
| Closed | -$291K | – | 1968 |
|
|
2022
Q1 | $291K | Sell |
5,349
-1,353
| -20% | -$73.6K | ﹤0.01% | 1649 |
|
|
2021
Q4 | $392K | Sell |
6,702
-284
| -4% | -$16.6K | ﹤0.01% | 1622 |
|
|
2021
Q3 | $276K | Sell |
6,986
-1,248
| -15% | -$49.3K | ﹤0.01% | 1607 |
|
|
2021
Q2 | $350K | Buy |
8,234
+1,479
| +22% | +$62.9K | ﹤0.01% | 1786 |
|
|
2021
Q1 | $416K | Buy |
6,755
+293
| +5% | +$18K | ﹤0.01% | 1571 |
|
|
2020
Q4 | $456K | Buy |
+6,462
| New | +$456K | ﹤0.01% | 1325 |
|